上关节囊重建中不同移植物类型的临床与功能结局:系统综述与Meta分析
该系统综述与Meta分析比较了上关节囊重建(SCR)使用真皮同种异体移植、阔筋膜张肌(TFL)自体移植、肱二头肌长头腱(LHBT)自体移植和猪异种移植的临床结局。结果显示真皮同种异体移植、TFL自体移植和LHBT自体移植均能显著改善ASES评分、VAS疼痛评分和前屈上举,且真皮同种异体移植与TFL自体移植的移植物撕裂率和再手术率相当。
要点
- 真皮同种异体移植、TFL自体移植和LHBT自体移植后ASES评分中位数分别为85.3、88.6和82.7。
- TFL自体移植与真皮同种异体移植的移植物撕裂率(9% vs 7%)和再手术率(3% vs 6%)相当。
- 在肩胛下肌完整/可修复的患者中,96%(73/76)假性瘫痪逆转。
核心结论
- 真皮同种异体移植、TFL自体移植和LHBT自体移植均是SCR的合适选择,能显著改善ASES评分、VAS疼痛评分和前屈上举。
- 真皮同种异体移植与TFL自体移植的移植物撕裂率和再手术率相当。
研究设计与样本
- Meta分析,证据等级4。
- 系统检索PubMed、Cochrane Library和Embase,纳入≥10例接受SCR且随访至少12个月并提供临床结局数据的研究。
- 真皮同种异体移植和TFL自体移植各纳入7项研究,LHBT自体移植2项,猪异种移植1项。
主要发现
- 术后ASES评分中位数(范围):真皮同种异体移植85.3(77.5-89),TFL自体移植88.6(73.7-94.3),LHBT自体移植82.7(80-85.4)。
- 术后VAS疼痛评分中位数:真皮同种异体移植0.8,TFL自体移植2.5,LHBT自体移植1.4。
- 术后前屈上举中位数:真皮同种异体移植159.0°,TFL自体移植147.0°,LHBT自体移植163.8°,猪异种移植151.4°。
- Meta分析显示TFL自体移植的合并移植物撕裂率为9%(95%CI,4%-16%),真皮同种异体移植为7%(95%CI,2%-13%)。
- 合并再手术率:TFL自体移植3%(95%CI,0%-7%),真皮同种异体移植6%(95%CI,2%-12%)。
临床怎么用
- SCR可选择真皮同种异体移植、TFL自体移植或LHBT自体移植,三者均能改善临床和功能结局。
- 真皮同种异体移植与TFL自体移植的移植物撕裂和再手术风险相当,选择时可综合考虑其他因素。
- 肩胛下肌完整/可修复的患者行SCR后假性瘫痪逆转率较高。
局限性
- 证据等级为4。
- 猪异种移植仅纳入1项研究,LHBT自体移植仅2项研究。
- 移植物撕裂率和再手术率的Meta分析仅针对真皮同种异体移植和TFL自体移植。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In recent years, superior capsular reconstruction (SCR) has emerged as a promising treatment for massive rotator cuff tears and has been performed with an array of graft options, most commonly dermal allograft and tensor fascia lata (TFL) autograft. PURPOSE: To compare the clinical outcomes, functional outcomes, and complication rates after SCR performed with dermal allograft, TFL autograft, long head of the biceps tendon (LHBT) autograft, and porcine xenograft. STUDY DESIGN: Meta-analysis; Level of evidence, 4. METHODS: PubMed, Cochrane Library, and Embase were systematically reviewed for studies that enrolled ≥10 patients who underwent SCR and presented clinical outcome data at a minimum follow-up of 12 months. When available, pre- and postoperative patient-reported outcome scores and clinical examination data were extracted. Outcome data were then compared by graft type. A meta-analysis was also conducted of graft tear and reoperation rates after SCR with dermal allograft and TFL autograft. RESULTS: Human dermal allograft and TFL autograft were each utilized in 7 studies, LHBT autograft in 2 studies, and porcine xenograft in 1 study. Dermal allograft, TFL autograft, and LHBT autograft demonstrated comparable median (range) postoperative American Shoulder and Elbow Surgeons scores of 85.3 (77.5-89), 88.6 (73.7-94.3), and 82.7 (80-85.4), respectively. The median postoperative pain scores per visual analog scale for dermal allograft, TFL autograft, and LHBT autograft were 0.8, 2.5, and 1.4. Median postoperative forward elevation was 159.0°, 147.0°, 163.8°, and 151.4° for dermal allograft, TFL autograft, LHBT autograft, and porcine xenograft. Meta-analysis demonstrated a comparable pooled graft tear rate between TFL autograft (9%; 95% CI, 4%-16%) and dermal allograft (7%; 95% CI, 2%-13%). Similarly, the pooled reoperation rate was similar for TFL autograft (3%; 95% CI, 0%-7%) and dermal allograft (6%; 95% CI, 2%-12%). Among the 3 studies with pre- and postoperative information on pseudoparalysis, 73 of 76 (96%) patients with an intact/repairable subscapularis had a reversal of their pseudoparalysis after SCR. CONCLUSION: Dermal allograft, TFL autograft, and LHBT autograft are all suitable options for SCR and demonstrate significant improvements in American Shoulder and Elbow Surgeons score, pain score per visual analog scale, and forward elevation. Moreover, dermal allograft and TFL autograft have comparable rates of graft tear and reoperation.
引用
- Lee A, Farooqi AS, Novikov D, et al. Clinical and Functional Outcomes by Graft Type in Superior Capsular Reconstruction: A Systematic Review and Meta-analysis. Am J Sports Med. 2021. PMID: 34633206. doi:10.1177/03635465211040440
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。